Annual Report 2016-2017 of Sun Pharmaceutical Industries Limited

It is a broadly described annual report of Sun Pharmaceutical Industries Limited in the year of 2016-2017. During the financial year, The Company’s Total Revenue Rs. 78,067.0 million. Profit before Tax Rs. 324.4 million. Net Profit after Tax for the year Rs. 349.5 million. The dividend on Equity shares Rs. 2,406.8. During the financial year, The Company has allotted 3000 equity shares of Rs. 1/- each under Sun Employee Stock Option Scheme – 2015 and 12,000 equity shares of Rs. 1/- each under Sun Employee Stock Option Plan – 2015.

The Board of Directors is pleased to recommend an equity dividend of Rs. 3.50/- per equity share of Rs.1/- each (previous year Rs. 1/- per equity share of Rs. 1/- each) for the year ended 31^st March 2017, subject to the approval of the equity shareholders at the ensuing Annual General Meeting.

More Annual Report of Sun Pharmaceutical Industries Limited: